Literature DB >> 20182795

Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.

Johanna M Ketolainen1, Emma-Leena Alarmo, Vilppu J Tuominen, Anne Kallioniemi.   

Abstract

Bone morphogenetic proteins (BMP) are extracellular signaling molecules that belong to the transforming growth factor β (TGFβ) superfamily. Bone morphogenetic proteins have diverse roles during development where they regulate proliferation, differentiation, and apoptosis in many different cell types by modulating the transcription of specific target genes. BMPs have also been implicated in both promotion and inhibition of cancer progression. We have recently shown that BMP4 is commonly expressed in breast cancer but its functional significance has not been previously explored. Our data demonstrate that in all nine breast cancer cell lines studied, BMP4 treatment leads to a dramatic growth suppression as a result of the induction of G1 arrest of the cell cycle. At the same time, BMP4 stimulates cell migration and invasion in a subset of these breast cancer cell lines. The BMP4-induced phenotypic changes were mediated through the activation of the canonical SMAD signaling pathway whereas no activation of MAP-kinases ERK1/2 or p38 was detected. Our results thus implicate that BMP4 is an important regulator of key phenotypic characteristics of cancer cells, cell growth, cell migration, and invasion, and that, similar to TGFβ, it possesses both tumor suppressive and oncogenic properties in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20182795     DOI: 10.1007/s10549-010-0808-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  36 in total

Review 1.  Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.

Authors:  Wei Pan; Qian Sun; Yang Wang; Jian Wang; Shui Cao; Xiubao Ren
Journal:  Tumour Biol       Date:  2015-04-01

2.  Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators.

Authors:  Philip Owens; Michael W Pickup; Sergey V Novitskiy; Anna Chytil; Agnieszka E Gorska; Mary E Aakre; James West; Harold L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

Review 3.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

Review 4.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

5.  Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.

Authors:  Chanèle Cyr-Depauw; Jason J Northey; Sébastien Tabariès; Matthew G Annis; Zhifeng Dong; Sean Cory; Michael Hallett; Jonathan P Rennhack; Eran R Andrechek; Peter M Siegel
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

6.  Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells.

Authors:  Lei Sun; Lesley A Mathews; Stephanie M Cabarcas; Xiaohu Zhang; Acong Yang; Ying Zhang; Matthew R Young; Kimberly D Klarmann; Jonathan R Keller; William L Farrar
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

7.  Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.

Authors:  Laura D Hover; Christian D Young; Neil E Bhola; Andrew J Wilson; Dineo Khabele; Charles C Hong; Harold L Moses; Philip Owens
Journal:  Cancer Lett       Date:  2015-07-30       Impact factor: 8.679

8.  Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model.

Authors:  Frida Danielsson; Marie Skogs; Mikael Huss; Elton Rexhepaj; Gillian O'Hurley; Daniel Klevebring; Fredrik Pontén; Annica K B Gad; Mathias Uhlén; Emma Lundberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

9.  BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation.

Authors:  Michael W Pickup; Laura D Hover; Eleanor R Polikowsky; Anna Chytil; Agnieszka E Gorska; Sergey V Novitskiy; Harold L Moses; Philip Owens
Journal:  Mol Oncol       Date:  2014-08-23       Impact factor: 6.603

Review 10.  A Molecular View of Pathological Microcalcification in Breast Cancer.

Authors:  Tanu Sharma; James A Radosevich; Geeta Pachori; Chandi C Mandal
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-01-15       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.